Unveiling the Role of Calcium Dobesilate's based on Multi-omics in Combatting Type 1 Diabetic Nephropathy

Read full text Summarise with VIRAT
Authors: Zhang Li, Tong Yin, X. Liu, Xiaoying Dong, Ping Liu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background: Diabetic nephropathy seriously endangers patients' lives and imposes a heavy economic burden on the country. Its molecular mechanism and therapeutic targets are not yet fully understood. A deeper understanding of the molecular mechanism of diabetic nephropathy is conducive to slowing down the disease progression and developing new strategies to reduce the risk of end-stage renal disease. Calcium dobesilate (CaD) has a vascular protective effect, but its systemic mechanism in type 1 diabetic nephropathy (T1DKD) has not yet been studied through multi-omics integration. Methods: We conducted transcriptomic, proteomic, and metabolomic profiling, using renal tissues obtained from rats from three groups (NC: non-diabetic; T1DKD: type-1 diabetic kidney disease; AS: CaD-treated T1DKD). Differential expression analysis, pathway enrichment (GO/KEGG/Reactome), and multi-omics integration (nine-quadrant plots, hierarchical clustering, correlation networks) were employed to dissect disease mechanisms and drug effects. Results: Transcriptomics identified 2,301 differentially expressed genes (DEGs) in T1DKD vs NC, enriched in extracellular matrix organization and ECM–receptor interaction, and cell adhesion (NES = -1.841, P

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Renal Diseases and Glomerulopathies Acute Kidney Injury Research

Publication details

Journal / source
Research Square
Publication date
25 March 2026
Language
EN
Document type
Preprint